Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 11/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6470858 | 1.00 | CHRM3 (0.34) | CHRM3SLC6A2SLC6A4SLC6A3PGR | |
| SCHEMBL7575276 | 0.99 | CHRM3 (0.33) | CHRM3SLC6A2SLC6A4SLC6A3TDP2 | |
| SCHEMBL7571273 | 0.96 | NR1I2 (0.32) | CHRM3TDP2 | |
| SCHEMBL7573529 | 0.94 | TDP2 (0.32) | TDP2 | |
| SCHEMBL6469961 | 0.83 | CHRM3 (0.34) | CHRM3SLC6A4SLC6A3 | |
| SCHEMBL8168093 | 0.81 | SLC6A4 (0.34) | CHRM3SLC6A4SLC6A3 | |
| SCHEMBL7940023 | 0.80 | — | — | |
| SCHEMBL6470486 | 0.79 | CHRM3 (0.30) | CHRM3 | |
| SCHEMBL7575254 | 0.79 | CHRM3 (0.30) | CHRM3 | |
| SCHEMBL6469988 | 0.79 | CHRM3 (0.30) | CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020019504-A1 | Stereospecific; low molecular weight | MITSUI CHEMICALS, INC. (JP) | 2002-02-14 | — | — | US | disclosed |
| US-6342568-B1 | ADDITION POLYMERIZATION OF HIGHLYS STEREOSPECIFIC AND LOW MOLECULAR WEIGHT POLYOLEFINS USING CATALYST COMPRISING CYCLOPENTADIENYL-SUBSTITUTED FLUORENE COMPOUND COMPLEXED WITH GROUP IV METAL | MITSUI CHEMICALS, INC. (JP) | 2002-01-29 | — | — | US | disclosed |
| EP-0955305-A1 | Metallocene compound, and process for preparing polyolefin by using it | Mitsui Chemicals, Inc. (JP) | 1999-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019504-A1 | Stereospecific; low molecular weight | RPLP1, RPS4Y1, POLA1 | CHRM3 1767/4885SLC6A2 4854/4885SLC6A4 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.